What not-for-profit leaders need to know in 2026
Posted on 12 Feb 2026
Our special NFP trends report distils the views of more than two dozen experts.
Posted on 28 Jan 2025
By Greg Thom, journalist, Institute of Community Directors Australia
The announcement of a new multi-million-dollar children’s medical research facility has been hailed as a shining example of the ability of targeted philanthropy to make a difference in people’s lives.
The Children’s Centre for Transplantation and Research at the Children’s Hospital at Westmead (CHW) in Sydney will focus on improving the lives of children requiring organ transplants.
The Centre will bring together world-leading research to improve the effectiveness of life-saving transplants and could help some children avoid the need for transplant surgery altogether.
The state-of-the-art facility has been made possible by a $3 million donation to the Sydney Children’s Hospital Foundation (SCHF) by the James Fairfax Foundation.
SCHF CEO Kristina Keneally said philanthropy had helped fund advances in research and technology that have improved the lives of sick children battling life-limiting medical conditions.
“Nonetheless, they still need our help to manage chronic and complex ongoing conditions,” she said.
“Philanthropy has the power to supercharge the care that these children receive. It accelerates research and paediatric health outcomes and delivers breakthroughs, milestones, turning points and world firsts.”
Edward Simpson, chair of the James Fairfax Foundation, said he believed the Foundation had a responsibility to support “transformative” projects such as the Children’s Centre for Transplantation and Research.
“This Centre has the potential to dramatically advance the health and wellbeing of unwell children facing life-threatening conditions,” he said.
“By investing in cutting-edge research and technology, we’re proud to give these children and their families new hope and longer lives.
“We hope our generosity inspires other organisations to join us in supporting this groundbreaking initiative.”
Keneally said the Centre would need an additional $1.77 million philanthropic contribution for its initial five years of development and ongoing operation.
“On behalf of all the children requiring a transplant each year, we’re so thankful for the James Fairfax Foundation’s generosity in getting us started, but there is still more work to be done, and more support needed.”
“Philanthropy has the power to supercharge the care that these children receive. It accelerates research and paediatric health outcomes and delivers breakthroughs, milestones, turning points and world firsts.”
Opening new medical frontiers
Professor Gordon Thomas, paediatric transplant surgeon at CHW, said organ transplantation was a vital component of healthcare for children with serious conditions.
However, a transplant, in its current form, is a temporary fix, not a cure.
“Transplants are highly invasive, can have long wait times and, at present, means a lifetime of immuno-suppressive drugs,” said Professor Thomas.
It is hoped the Foundation's donation will help the Centre to become a world leader in trialling potential therapies using machine perfusion.
A perfusion machine enables donated organs to live outside the body, and the Centre will use it to research ways to decrease the possibility of rejection of a donor organ.

The goal will be to use this same research to genetically repair organs that are not working properly, without the need for a transplant.
Professor Ian Alexander, head of the Gene Therapy Research Unit at CHW, said the hospital was collaborating with the Children’s Medical Research Institute and Royal Prince Alfred Hospital to carry out preliminary work involving adult organs on this type of machine.
He said the team had recently become the first medical researchers on the planet to test gene transfer technology in this way.
“In this proposed new facility, where organs can be maintained on these sophisticated pieces of equipment, we can actually go in and test whether our gene repair technology and experimental therapies work in human tissue,” said Professor Alexander.
“This, in turn, dramatically increases the likelihood of therapeutic success when trialled in children.”
Posted on 12 Feb 2026
Our special NFP trends report distils the views of more than two dozen experts.
Posted on 11 Feb 2026
The ballooning cost-of-living crisis is affecting Australian families to the extent that many…
Posted on 11 Feb 2026
Rev. Salesi Faupula is the Uniting Church’s moderator for the synod of Victoria and Tasmania. Born…
Posted on 11 Feb 2026
Service providers have expressed cautious support for the federal government’s Thriving Kids…
Posted on 11 Feb 2026
Australia’s not-for-profits need strategic investment by the federal government to support the…
Posted on 11 Feb 2026
For the first time, charities commissioner Sue Woodward has confirmed the Australian Charities and…
Posted on 11 Feb 2026
Opinions polls insist Pauline Hanson's fortunes are on the rise, but it is likely that enthusiasm…
Posted on 10 Feb 2026
As my family dropped our teenage son off at the airport in the first week of January to embark on a…
Posted on 04 Feb 2026
Last week’s announcement that women made up only one-third of recipients in the Australia Day…
Posted on 04 Feb 2026
As we move into 2026, I can’t help but think the world is wobbling a little.
Posted on 04 Feb 2026
An academic studying the phenomenon of “headline fatigue” – where news consumers tune out of…
Posted on 04 Feb 2026
In this time of escalating climate impact, the head of Australian Ethical Foundation, Kate…